Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:05 PM ET 5/24/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.00 | 0.00 | 0.00 |
| EPS, GAAP | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 0.00 | 0.00 | 0.00 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 0.00 | 0.00 | 0.00 |
| EPS, GAAP | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 0.00 | 0.00 | 0.00 |
| NVS | Industry Average | |
| P/E (TTM) | 12.83 | NA |
| P/E (Forward) | 0.00 | NA |
| PEG Ratio | 0.00 | 0.00 |
| Price/Sales | 0.00 | 0.00 |
| Beta | 0.00 | 0.00 |
| 6:11 PM | 5/18/2012 | FTS International To Form Saudi Arabia Joint Venture With Summit Technologies |
| 5:45 PM | 5/14/2012 | WSJ BLOG/Health: New Caution Urged Over Sole Oral MS Drug On the Market |
| 5/24/2012 | Teva Rising Despite Guidance Cuts (Barrons.com) |
| 5/21/2012 | India's Proposals to Cap Drug Prices Sparks Debate (WSJ.com) |
| 5/14/2012 | FDA Concludes Safety Review of MS Drug (WSJ.com) |
| 5/11/2012 | Investment Opportunities Popping Up in Europe (SmartMoney.com) |
| 5/11/2012 | Opportunities in Europe's Wreckage (WSJ.com) |
| 5/11/2012 | India Vows Drug Approval Reforms (WSJ.com) |
| 5/10/2012 | Drug Makers Refute India Probe Findings (WSJ.com) |
| 5/10/2012 | Glaxo: Followed Indian Rules (WSJ.com) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)
